Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors

American Journal of Surgery

Volumn 173, Issue 2, 1997, Pages 103-109

  Ku, Yonson ^a   Fukumoto, Takumi ^a   Tominaga, Masahiro ^a   Iwasaki, Takeshi ^a   Maeda, Ichiro ^a   Kusunoki, Nobuya ^a   Obara, Hidefumi ^a   Sako, Masao ^a   Suzuki, Yasuyuki ^a   Kuroda, Yoshikazu ^a   Saitoh, Yoichi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHARCOAL; DOXORUBICIN;

ADULT; ALOPECIA; ARTICLE; BALLOON CATHETER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; HEMATURIA; HEMODYNAMIC PARAMETERS; HEMOLYSIS; HEMOPERFUSION; HEPATIC VEIN; HEPATITIS; HUMAN; INTERMETHOD COMPARISON; INTRAARTERIAL DRUG ADMINISTRATION; LEUKOPENIA; LIVER CARCINOMA; LIVER TUMOR; MALE; NAUSEA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0030890464     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(96)00422-9     Document Type: Article

References (14)

1. Krementz ET. Regional perfusion. Cancer. 1986;57:416-432.
2. Woodhall MR, Mahaley MS. Isolated perfusion in treatment of advanced carcinoma: brain and face tumors. Am J Surg. 1963;105:624-627.
3. Mulcare RJ, Solis A, Fortner JG. Isolation and perfusion of the liver for cancer chemotherapy. J Surg Res. 1973;15:87-95.
4. Creech Jr O, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg. 1958;148:616-632.
5. Aigner KR, Walther H, Link LH. Isolated liver perfusion with MMC/5-FU: Surgical technique, pharmacokinetics, clinical results. Contrib Oncol. 1988;29:229-246.
6. Ku Y, Saitoh M, Nishiyama H, et al. Extracorporeal adriamycin removal following hepatic arterial infusion: use of direct hemoperfusion combined with veno-venous bypass. J Jpn Surg Soc. 1989;90:1758-1764.
7. Ku Y, Saitoh M, Nishiyama H, et al. Extracorporeal removal of anticancer drugs in hepatic arterial infusion: the effect of direct hemoperfusion combined with veno-venous bypass. Surgery. 1990;107:273-281.
8. Maekawa Y, Ku Y, Saitoh Y. Extracorporeal cisplatin removal using direct hemoperfusion under hepatic venous isolation for hepatic arterial chemotherapy: an experimental study on pharmacokinetics. Surgery Today. 1993;23:58-62.
9. Ku Y, Fukumoto T, Iwasaki T, et al. Clinical pilot study on high-dose intra-arterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. Surgery. 1995;117:510-519.
10. Robert J. Extraction of anthracyclines from biologic fluids for HPLC evaluation. J Liquid Chromatogr. 1980;3:1561-1572.
11. Beheshti MV, Denny DF Jr, Glickman MG, et al. Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. JVIR. 1992;3:453-458.
12. Curley SA, Newman RA, Dougherty TB, et al. Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study. Ann Surg Oncol. 1994;1:389-399.
13. Tominaga M, Ku Y, Oyanagi H, Saitoh Y. The direct hemodynamic effects of dopamine on hepatic blood flow in the dog: use of direct hemoperfusion under hepatic venous isolation. J Jpn Surg Soc. 1992;93:26-35.
14. Kletschka HD, Rafferty EH, Olsen DA, et al. Development of efficient atraumatic blood pump. A review of the literature concerning in vitro testing of blood pumps for hemolysis. Minnesota Med. 1975;58:757-781.